Kitasamycin antibody/antigen (BSA/OVA/KLH conjugated hapten)
anti-Kitasamycin antibody and Carrier-coupled antigen/immunogen (hapten-carrier conjugates)
Go to Antibiotics diagnostics products collection >>
Product information
Catalog No. | Description | US $ Price (per mg) |
---|---|---|
GMP-SMT-31-1 | 1. BSA-Kitasamycin 2. Anti-Kitasamycin mouse monoclonal antibody | $2709.00 |
GMP-SMT-31-2 | 1. OVA-Kitasamycin 2. Anti-Kitasamycin mouse monoclonal antibody | $2709.00 |
GMP-SMT-31-3 | 1. BSA-Kitasamycin 2. Anti-Kitasamycin human monoclonal antibody | $2709.00 |
GMP-SMT-31-4 | 1. OVA-Kitasamycin 2. Anti-Kitasamycin human monoclonal antibody | $2709.00 |
GMP-SMT-31-Ag-1 | BSA-Kitasamycin | $756.00 |
GMP-SMT-31-Ag-2 | OVA-Kitasamycin | $756.00 |
GMP-SMT-31-Ab-1 | Anti-Kitasamycin mouse monoclonal antibody | $1953.00 |
GMP-SMT-31-Ab-2 | Anti-Kitasamycin human monoclonal antibody | $1953.00 |
Size: 1mg | 10mg | 100mg
Product Description
BSA-Kitasamycin
Cat No. | GMP-SMT-31-Ag-1 |
Bioactivity validation | Competitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody; |
Products description | Competitive immunoassay-validated hapten-carrier conjugates BSA-Kitasamycin with anti-Hapten antibody. The hapten hapten-carrier conjugates BSA-Kitasamycin had been validated with our anti-Hapten antibody Anti-Kitasamycin mouse monoclonal antibody via competitive ELISA test. |
Application | ELISA tests and other immunoassays; Lateral flow immunoassay (LFIA); LTIA Immunonephelometry Time-resolved Fluorescence Immunoassay (TRFIA) |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
OVA-Kitasamycin
Cat No. | GMP-SMT-31-Ag-2 |
Bioactivity validation | Competitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody; |
Products description | Competitive immunoassay-validated hapten-carrier conjugates OVA-Kitasamycin with anti-Hapten antibody. The hapten hapten-carrier conjugates OVA-Kitasamycin had been validated with our anti-Hapten antibody Anti-Kitasamycin mouse monoclonal antibody via competitive ELISA test. |
Application | ELISA tests and other immunoassays; Lateral flow immunoassay (LFIA); LTIA Immunonephelometry Time-resolved Fluorescence Immunoassay (TRFIA) |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Anti-Kitasamycin mouse monoclonal antibody
Cat No. | GMP-SMT-31-Ab-1 |
Host of Antibody | Mouse IgG |
Bioactivity validation | Competitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody; Lateral flow immunoassay (LFIA); |
ELISA IC50 (ppb) | 20.00 |
Products description | The anti-Hapten antibody against hapten Kitasamycin had been validated with our hapten hapten-carrier conjugates BSA-Kitasamycin via competitive ELISA test. |
Application | ELISA tests and other immunoassays; Lateral flow immunoassay (LFIA); LTIA Immunonephelometry Time-resolved Fluorescence Immunoassay (TRFIA) |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Anti-Kitasamycin human monoclonal antibody
Cat No. | GMP-SMT-31-Ab-2 |
Host of Antibody | Human IgG1 |
Bioactivity validation | Competitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody; Lateral flow immunoassay (LFIA); |
ELISA IC50 (ppb) | 20.00 |
Products description | The anti-Hapten antibody against hapten Kitasamycin had been validated with our hapten hapten-carrier conjugates BSA-Kitasamycin via competitive ELISA test. |
Application | ELISA tests and other immunoassays; Lateral flow immunoassay (LFIA); LTIA Immunonephelometry Time-resolved Fluorescence Immunoassay (TRFIA) |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Biomarker Information
1. Kitasamycin in Veterinary Drug Residues and Additives:
Kitasamycin is a macrolide antibiotic that holds a crucial position in the field of veterinary medicine, particularly concerning bacterial infections in livestock and poultry. It is classified as a veterinary antibiotic and is primarily used in the management of poultry and swine. Kitasamycin serves a dual role in this context, acting as a growth promoter and a therapeutic agent. Its growth-promoting attributes enhance feed efficiency and accelerate animal growth, thereby contributing significantly to the overall productivity of the animal agriculture sector. In addition to this, Kitasamycin also exhibits therapeutic potential in treating infections caused by susceptible microorganisms in animals, further promoting the well-being of livestock.
The role of Kitasamycin in veterinary drug residues and additives is multifaceted and pivotal for both animal health and human safety. Here, we delve into the significance of Kitasamycin in veterinary applications, its measurement, and the importance of monitoring Kitasamycin levels in animal-derived products.
2. Significance of Measuring Kitasamycin:
The measurement of Kitasamycin plays a crucial role for various scientific and regulatory reasons. To begin with, accurate quantification of Kitasamycin is essential in veterinary medicine to determine precise dosing regimens for animals. This ensures that the antibiotic is administered at the correct dosage, preventing the under or overutilization of this crucial drug. Proper dosage management is pivotal not only for maintaining animal health but also for mitigating the emergence of antibiotic resistance, a growing concern in the field of animal agriculture.
Secondly, the monitoring of Kitasamycin levels in animal products is of paramount importance to guarantee food safety and quality. Excessive residues of Kitasamycin in meat, milk, or eggs can have detrimental effects on human health, making accurate measurement methods indispensable. Reliable and sensitive assays, developed using anti-Kitasamycin antibodies and competitive antigens, are instrumental in ensuring adherence to regulatory limits and safeguarding the health and safety of both animals and consumers. This scientific rigor is essential to address the complexities surrounding Kitasamycin in veterinary applications.
3. Monitoring Kitasamycin Residues in Animal-Derived Products:
The presence of Kitasamycin residues in animal-derived products, including meat, milk, and eggs, is a subject of critical concern for regulatory agencies, veterinarians, and the food industry. It is imperative to employ robust analytical methods to monitor and control these residues.
4. Regulatory Standards and Compliance:
Regulatory standards are in place to limit the levels of Kitasamycin residues in animal-derived products. These standards are established to ensure that the food consumed by humans is safe and free from excessive antibiotic residues. Non-compliance with these standards can lead to serious health risks and economic consequences for the livestock and food industries.
5. Analytical Techniques for Kitasamycin Measurement:
The precise measurement of Kitasamycin in animal-derived products requires sophisticated analytical techniques. High-performance liquid chromatography (HPLC), liquid chromatography-mass spectrometry (LC-MS), and enzyme-linked immunosorbent assays (ELISA) are some of the methods employed for this purpose.
HPLC is a powerful separation technique that can separate and quantify individual components in a mixture. It has been widely used for the quantification of Kitasamycin in various samples. LC-MS, on the other hand, combines the separation capabilities of liquid chromatography with the quantitative and qualitative capabilities of mass spectrometry, offering high sensitivity and selectivity for Kitasamycin analysis.
ELISA, which utilizes antibodies to detect and quantify specific substances, is particularly useful for screening Kitasamycin residues in animal products. Our anti-Kitasamycin antibodies and competitive antigens have been developed to provide reliable and accurate results in ELISA-based assays.
6. The Role of Antibodies in Kitasamycin Detection:
Antibodies are essential tools in the development of sensitive and specific assays for Kitasamycin measurement. Anti-Kitasamycin antibodies are designed to bind specifically to Kitasamycin molecules, allowing for their selective detection in complex samples.
7. Competitive Antigens in ELISA:
In ELISA assays, competitive antigens are used to compete with Kitasamycin in the sample for binding to the anti-Kitasamycin antibodies. This competition results in a signal that is inversely proportional to the concentration of Kitasamycin in the sample, allowing for quantitative measurement.
8. Advantages of ELISA in Kitasamycin Detection:
ELISA offers several advantages in Kitasamycin detection. It is a rapid and cost-effective method, making it suitable for high-throughput analysis. ELISA is also highly specific, minimizing the chances of false positives. Furthermore, it can detect Kitasamycin residues at low concentrations, ensuring compliance with regulatory limits.
9. Conclusion:
Kitasamycin plays a crucial role in veterinary medicine as both a growth promoter and a therapeutic agent. Ensuring the accurate measurement of Kitasamycin is essential for proper animal care, preventing antibiotic resistance, and safeguarding the quality and safety of animal-derived products. Monitoring Kitasamycin residues in these products is a regulatory requirement, and reliable analytical techniques, such as ELISA using anti-Kitasamycin antibodies and competitive antigens, play a vital role in meeting these standards. This scientific approach ensures the well-being of both animals and consumers, underscoring the importance of precise Kitasamycin measurement in veterinary applications.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.